Matthew Silva to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Matthew Silva has written about Platelet Aggregation Inhibitors.
Connection Strength
0.600
-
Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manag. 2006; 2(1):39-48.
Score: 0.224
-
Silva MA, Gandhi PJ. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? J Clin Pharm Ther. 2004 Dec; 29(6):497-510.
Score: 0.208
-
Malloy RJ, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013 Oct; 35(10):1490-1500.e7.
Score: 0.096
-
Serebruany V, Rao SV, Silva MA, Donovan JL, Kannan AO, Makarov L, Goto S, Atar D. Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications. Eur Heart J. 2010 Jan; 31(2):227-35.
Score: 0.073